DE60217292D1 - Veterinärmedizinische dermatologische zusammensetzung - Google Patents

Veterinärmedizinische dermatologische zusammensetzung

Info

Publication number
DE60217292D1
DE60217292D1 DE60217292T DE60217292T DE60217292D1 DE 60217292 D1 DE60217292 D1 DE 60217292D1 DE 60217292 T DE60217292 T DE 60217292T DE 60217292 T DE60217292 T DE 60217292T DE 60217292 D1 DE60217292 D1 DE 60217292D1
Authority
DE
Germany
Prior art keywords
veterinary medicine
dermatological composition
fur
skin
sphingoid base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60217292T
Other languages
English (en)
Other versions
DE60217292T2 (de
Inventor
Jean-Claude Allart
Jean-Marie Lefevre
Jacques Peyrot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermaconcept JMC SARL
Original Assignee
Dermaconcept JMC SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8164268&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60217292(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dermaconcept JMC SARL filed Critical Dermaconcept JMC SARL
Application granted granted Critical
Publication of DE60217292D1 publication Critical patent/DE60217292D1/de
Publication of DE60217292T2 publication Critical patent/DE60217292T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60217292T 2001-01-29 2002-01-29 Veterinärmedizinische dermatologische zusammensetzung Expired - Lifetime DE60217292T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2001/001019 WO2002060405A1 (en) 2001-01-29 2001-01-29 Veterinary dermatologic composition comprising a sphingoid base and/or a sphingoid base derivative
WOPCT/EP01/01019 2001-01-29
PCT/EP2002/001120 WO2002060406A2 (en) 2001-01-29 2002-01-29 Veterinary dermatologic composition

Publications (2)

Publication Number Publication Date
DE60217292D1 true DE60217292D1 (de) 2007-02-15
DE60217292T2 DE60217292T2 (de) 2007-05-31

Family

ID=8164268

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60217292T Expired - Lifetime DE60217292T2 (de) 2001-01-29 2002-01-29 Veterinärmedizinische dermatologische zusammensetzung

Country Status (9)

Country Link
US (2) US8246972B2 (de)
EP (1) EP1355626B1 (de)
AT (1) ATE350106T1 (de)
CA (1) CA2436414C (de)
DE (1) DE60217292T2 (de)
DK (1) DK1355626T3 (de)
ES (1) ES2275846T3 (de)
PT (1) PT1355626E (de)
WO (2) WO2002060405A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010688A1 (it) 2001-11-21 2003-05-21 Univ Roma Composti immunoregolatori.
AU2002349521A1 (en) * 2002-08-14 2004-03-03 Tae-Yoon Kim A composition comprising phytospingosine derivatives for apoptosis induction
GB0513431D0 (en) 2005-06-30 2005-08-10 Kherion Technology Ltd Prophylactic compositions and uses
DE102011109546A1 (de) * 2011-08-03 2013-02-07 Evonik Goldschmidt Gmbh Verwendung von Sphinganin zur Verbesserung des visuellen Erscheinungsbildes von Haut und Haar
KR101288776B1 (ko) * 2011-12-07 2013-07-22 가톨릭대학교 산학협력단 신규한 피토스핑고신 유도체 및 이를 포함하는 염증성 피부질환과 피부과다각화증질환 예방 및 개선용 화장료 조성물
KR101342851B1 (ko) 2011-12-07 2013-12-17 가톨릭대학교 산학협력단 신규한 피토스핑고신 유도체 및 이를 포함하는 염증성 피부질환, 자가면역질환 및 피부과다각화증질환 예방 및 치료용 조성물
EP3259990A1 (de) * 2016-06-20 2017-12-27 Ceva Sante Animale Verfahren zur bekämpfung von ektoparasiten bei nichtmenschlichen säugern
EP3600228B1 (de) 2017-03-27 2020-09-30 Evonik Operations GmbH Verfahren und erzeugnis zur herstellung ceramidhaltiger formulierungen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2007507C (en) * 1989-02-03 1998-05-19 Yasuyuki Igarashi Sphingosine and n-methyl-sphingosine as inhibitor of cell growth
WO1995003028A1 (en) * 1993-07-23 1995-02-02 Morris Herstein Cosmetic, skin-renewal stimulating composition with long-term irritation control
DE19602108A1 (de) * 1996-01-22 1997-07-24 Beiersdorf Ag Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Substanzen
DE19602111A1 (de) * 1996-01-22 1997-07-24 Beiersdorf Ag Gegen Bakterien, Mycota, Parasiten, Protozoen und Viren wirksame Zusammensetzungen auf der Basis von Squalen, Sphingolipiden und Fettsäuren
FR2747307B1 (fr) * 1996-04-11 1998-07-10 Ravi Shrivastava Application a titre de medicament des ceramides et compositions notamment pharmaceutiques les renfermant
JP2000513745A (ja) * 1997-05-02 2000-10-17 ギスト ブロカデス ベスローテン フェンノートシャップ 局所用抗菌組成物
US5882665A (en) * 1997-11-18 1999-03-16 Elizabeth Arden Co., Division Of Conopco, Inc. Phytosphingosine salicylates in cosmetic compositions
US6306383B1 (en) * 1998-09-16 2001-10-23 Wilson T Crandall Method for topical treatment of scars with protein kinase C inhibitors
BR0009265A (pt) * 1999-03-09 2001-11-20 Cosmoferm Bv Derivados com base em esfingóide e usos destes
US6361806B1 (en) * 2000-02-23 2002-03-26 Michael P. Allen Composition for and method of topical administration to effect changes in subcutaneous adipose tissue

Also Published As

Publication number Publication date
US9198855B2 (en) 2015-12-01
US20130190401A1 (en) 2013-07-25
WO2002060406A8 (en) 2003-10-30
WO2002060405A1 (en) 2002-08-08
CA2436414C (en) 2010-09-28
DE60217292T2 (de) 2007-05-31
WO2002060405A8 (en) 2003-10-30
ES2275846T3 (es) 2007-06-16
US8246972B2 (en) 2012-08-21
EP1355626B1 (de) 2007-01-03
CA2436414A1 (en) 2002-08-08
EP1355626A2 (de) 2003-10-29
PT1355626E (pt) 2007-03-30
WO2002060406A2 (en) 2002-08-08
DK1355626T3 (da) 2007-05-07
US20050037035A1 (en) 2005-02-17
WO2002060406A3 (en) 2003-02-20
ATE350106T1 (de) 2007-01-15

Similar Documents

Publication Publication Date Title
BR0115452A (pt) Compostos tendo atividade fungicida e processos para fabricação e uso dos mesmos
BR0315296A (pt) Derivados do ciclohexanol espirocìclicos
HN1999000124A (es) Derivados de pirazol substituido.
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
UY26130A1 (es) Compuestos para tratar la obesidad
PA8571001A1 (es) 2-(2,6-diclorofenil)-diarilimidazoles
BR0312729A (pt) Novos derivados de indol-3-enxofre
BR0307429A (pt) Composto, uso do mesmo, composição farmacêutica, e, método para o tratamento de distúrbios ou doenças relacionadas com receptor de histamina h3
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
BR0312464A (pt) Inibidores de tirosina quinases
BR0212468A (pt) Compoto de uréia ativos como antagonistas de receptor de vanilóides para o tratamento de dor
SE0101387D0 (sv) Novel compounds
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
ES2190803T3 (es) Iminas ciclicas como pesticidas.
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
BRPI0418099A (pt) compostos, composição farmacêutica, e uso de um composto
BRPI0415179A (pt) derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
ATE495187T1 (de) Dalda-analoge und ihre verwendung
SV2004001481A (es) Derivados de nicotinamida utiles como inhibidores de pde4" ref. pc22065a
ATE385769T1 (de) Topisches präparat
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
DE50012571D1 (de) Biotin enthaltende galenische formulierung
BR0308133A (pt) Forma polimórfica cristalina de cloridrato de irinotecan
DE60217292D1 (de) Veterinärmedizinische dermatologische zusammensetzung
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition